2025 annual financial data
Vicore Pharma Holding 2025 Operating margin
Direct answer
Operating margin was -11,905.82%.
Operating income was -454,445,000 SEK and net income was -477,474,000 SEK.
Operating cash flow was -375,737,000 SEK.
Get free Vicore Pharma Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,817,000 SEK
- Operating income
- -454,445,000 SEK
- Net income
- -477,474,000 SEK
- Operating cash flow
- -375,737,000 SEK